UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-11-02 | Future report Set alerts | |
| Q2 2022 | 2022-08-03 | -0.79 | -0.79 |
| Q1 2022 | 2022-05-04 | -0.68 | -0.68 |
| Q4 2021 | 2022-02-28 | -0.72 | -0.72 |
| Q3 2021 | 2021-11-04 | -0.45 | -0.45 |
| Q2 2021 | 2021-08-04 | -0.58 | -0.58 |
| Q1 2021 | 2021-05-05 | -0.48 | -0.48 |
| Q4 2020 | 2021-02-24 | -0.61 | -0.61 |
| Q3 2020 | 2020-11-04 | 0.00 | 0.00 |
| Q2 2020 | 2020-08-05 | -0.35 | -0.35 |
| 2016-06-21 | Reiterated Rating | BMO Capital Markets | Outperform | $4.00 |
| 2016-06-21 | Reiterated Rating | Leerink Swann | Outperform | $4.00 |
| 2016-05-10 | Reiterated Rating | BMO Capital Markets | Buy | |
| 2016-05-10 | Reiterated Rating | Wells Fargo | Buy | |
| 2016-05-10 | Reiterated Rating | Wells Fargo & Co. | Buy | |
| 2016-04-11 | Initiated Coverage | BMO Capital Markets | Outperform | $4.00 |
| 2016-03-07 | Reiterated Rating | HC Wainwright | Buy | $9.00 |
| 2016-03-05 | Initiated Coverage | Leerink Swann | Buy | |
| 2016-03-04 | Reiterated Rating | Leerink Swann | Outperform | $8.00 to $4.00 |
| 2016-02-24 | Reiterated Rating | HC Wainwright | Buy | $9.00 |
| 2015-12-07 | Reiterated Rating | Leerink Swann | Buy | $10.00 to $8.00 |
| 2015-12-07 | Reiterated Rating | Wedbush | Outperform | $10.00 |
| 2015-12-03 | Initiated Coverage | Wells Fargo | Outperform | |
| 2015-11-05 | Reiterated Rating | Cowen and Company | Outperform | |
| 2015-10-15 | Reiterated Rating | Cowen and Company | Outperform | |
| 2015-10-06 | Initiated Coverage | Raymond James | Outperform | $8.00 |
| 2015-10-06 | Reiterated Rating | Leerink Swann | Outperform | |
| 2015-10-06 | Initiated Coverage | Raymond James Financial Inc. | Outperform | $8.00 |
| 2015-06-17 | Reiterated Rating | BMO Capital Markets | Outperform | $15.00 |
| 2015-06-08 | Reiterated Rating | BMO Capital Markets | Outperform | $15.00 |
| 2015-06-01 | Initiated Coverage | Leerink Swann | Outperform | $10.00 |
| 2015-05-11 | Boost Price Target | HC Wainwright | Buy | $9.00 to $11.00 |
| 2015-05-06 | Set Price Target | BMO Capital Markets | Buy | $15.00 |
| 2014-12-19 | Set Price Target | HC Wainwright | Buy | $9.00 |
| 2014-09-08 | Initiated Coverage | HC Wainwright | Buy | $9.00 |
| 2013-10-28 | Initiated Coverage | Cowen and Company | Outperform | |
| 2013-10-28 | Initiated Coverage | Wedbush | Outperform | $14.00 |
| 2013-10-28 | Initiated Coverage | BMO Capital Markets | Outperform | $14.00 |
| 2016-06-21 | Reiterated Rating | BMO Capital Markets | Outperform | $4.00 |
| 2016-06-21 | Reiterated Rating | Leerink Swann | Outperform | $4.00 |
| 2016-05-10 | Reiterated Rating | BMO Capital Markets | Buy | |
| 2016-05-10 | Reiterated Rating | Wells Fargo | Buy | |
| 2016-05-10 | Reiterated Rating | Wells Fargo & Co. | Buy |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In FATE 170 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| Redmile Group, LLC | 12.96M |
| Capital World Investors | 8.23M |
| BlackRock Inc. | 7.92M |
| Vanguard Group, Inc | 7.81M |
| STATE STREET CORP | 4.38M |
| JOHNSON & JOHNSON | 3.38M |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3.14M |
| JPMORGAN CHASE & CO | 2.03M |
| GEODE CAPITAL MANAGEMENT, LLC | 1.50M |
| FMR LLC | 1.46M |
| HENDERSON GROUP PLC | 1.42M |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 1.39M |
| MORGAN STANLEY | 1.37M |
| Sumitomo Mitsui Trust Holdings, Inc. | 1.29M |
| Nikko Asset Management Americas, Inc. | 1.29M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| NELSEN ROBERT | 12.03% (2473188) | AGIO / FATE / KYTH / SAGE / |
| ARCH VENTURE FUND VI LP | 12.03% (2473188) | AKAO / FATE / PLCC / |
| VENROCK ASSOCIATES V LP | 12.03% (2473187) | ANAC / CERU / CSLT / FATE / RCPT / ZLTQ / |
| Nashat Amir | 12.03% (2473186) | BIND / FATE / RCPT / |
| Polaris Venture Management Co. V, L.L.C. | 12.03% (2473186) | BIND / CERU / FATE / GNCA / TRVN / |
| OVP VENTURE PARTNERS VII LP | 7.29% (1499467) | FATE / |
| MENDLEIN JOHN | 0.76% (156774) | FATE / |
| Wolchko J Scott See remarks | 0.61% (124881) | FATE / |
| Shoemaker Daniel D Chief Technology Officer | 0.44% (90591) | FATE / |
| RASTETTER WILLIAM H | 0.41% (83333) | CERU / FATE / ILMN / NBIX / RCPT / RGLS / |
| TAHL CINDY General Counsel and Secretary | 0.22% (45418) | FATE / |
| FATE THERAPEUTICS INC General Counsel and Secretary | 0.21% (43863) | FATE / |
| ABBOT STEWART Chief Development Officer | 0.21% (43863) | FATE / |
| Weyer Christian See remarks | 0.15% (30429) | FATE / ICPT / |
| Storgard Chris Chief Medical Officer | 0.04% (9090) | FATE / |
| Flynn Peter D See remarks | 0.03% (6505) | FATE / OREX / |
| Multani Pratik S Chief Medical Officer | 0.01% (3024) | FATE / RXDX / |
UM